anaesthetic management of a diabetic patient with autonomic dysfunction posted for total abdominal hysterectomy

Reading File
Finding Sources
Finding Sources
Finding Sources
Searching PubMed

diabetes AND perioperative

Searching the Web

2024 perioperative management diabetes autonomic neuropathy anesthesia guideline

Reading File
Reading File
Reading File
Reading Web Page

https://libguides.anzca.edu.au/pomtrain/U3M10

Searching PubMed

diabetic autonomic neuropathy AND anesthesia

Anaesthetic management

A diabetic patient with autonomic dysfunction undergoing total abdominal hysterectomy should be treated as high risk for haemodynamic instability, silent myocardial ischaemia, aspiration, perioperative dysglycaemia, renal injury, infection, and postoperative ileus.
Diabetic autonomic neuropathy may cause resting tachycardia, fixed heart-rate response, orthostatic hypotension, arrhythmia, gastroparesis, impaired thermoregulation, bladder dysfunction, and reduced awareness of hypoglycaemia. Diabetes is also associated with ischaemic heart disease, chronic kidney disease, limited cervical mobility, and postoperative cardiac, renal, and wound complications. Miller's Anesthesia, 10e, p. 3964. Autonomic neuropathy specifically includes cardiac arrhythmias, postural hypotension, and gastroparesis. Harrison’s Principles of Internal Medicine, 22e, p. 3647.

1. Preoperative assessment and optimization

Assess diabetes
  • Establish type of diabetes, duration, usual glucose values, HbA1c, current treatment, insulin regimen/pump, episodes of hypoglycaemia, DKA/HHS, and diabetic complications.
  • Check capillary blood glucose on arrival. Obtain HbA1c if not available, though surgery should not be delayed solely for this unless control is very poor or metabolic decompensation is suspected.
  • Check electrolytes, renal function, urine ketones or blood ketones when indicated, ECG, and full blood count.
  • Schedule as the first case to minimize fasting disruption. Miller's Anesthesia, 10e, p. 3964.
Assess autonomic dysfunction
  • Record supine and standing BP, pulse, and symptoms of postural dizziness/syncope.
  • Look for resting tachycardia, fixed heart rate, exercise intolerance, arrhythmias, and previous unexplained hypotension under anaesthesia.
  • Assess for silent coronary disease: ECG for all; obtain echocardiography or cardiology review if symptoms, poor functional capacity, heart failure, abnormal ECG, or high cardiac risk.
  • Review antihypertensives, diuretics, and drugs used for orthostatic hypotension. Avoid preoperative dehydration.
Aspiration assessment
  • Ask specifically about early satiety, bloating, reflux, nausea/vomiting, and known gastroparesis.
  • Treat symptomatic gastroparesis as a high aspiration-risk state. Consider non-particulate antacid, H2 blocker/PPI, and metoclopramide where appropriate, with rapid-sequence induction if general anaesthesia is used.
Diabetes medications
  • Omit short-acting meal-related insulin while fasting, but do not omit basal insulin completely, especially in type 1 diabetes.
  • Withhold oral hypoglycaemic drugs according to local protocol.
  • SGLT2 inhibitors need advance cessation because of perioperative euglycaemic ketoacidosis risk. Check ketones if unwell, acidotic, or glucose is unexpectedly raised.
  • For GLP-1 receptor agonists, assess symptoms and aspiration risk, particularly delayed gastric emptying. Current guidance is risk-based rather than a uniform withholding rule.

2. Intraoperative plan

Monitoring and access

  • Standard ASA monitoring plus frequent non-invasive BP cycling from before induction.
  • Insert a radial arterial line before induction or immediately after it in significant autonomic dysfunction, expected major blood loss, labile BP, or major cardiovascular/renal disease.
  • Two large-bore IV cannulae, group and cross-match blood, active warming, urine output monitoring.
  • Check glucose at induction and at least hourly during major abdominal surgery or while receiving insulin infusion.

Glycaemic management

  • Aim to avoid both hypo- and hyperglycaemia. A practical intraoperative target is approximately 100-180 mg/dL (5.6-10 mmol/L), allowing modestly higher values rather than inducing hypoglycaemia.
  • For a prolonged open hysterectomy, insulin-treated diabetes, poor preoperative control, or glucose persistently above target, use a variable-rate IV insulin infusion with dextrose-containing fluid and potassium monitoring according to institutional protocol.
  • Never rely on symptoms to detect hypoglycaemia in an anaesthetized patient. Confirm with point-of-care blood glucose testing.
  • Continuous glucose monitors can be useful adjuncts but should not replace validated point-of-care or laboratory glucose measurements intraoperatively. A recent systematic review found variable perioperative accuracy and supports confirmatory testing (Carlier et al., 2025).

Choice of anaesthesia

General anaesthesia is usually appropriate for total abdominal hysterectomy.
  • Use careful titration of induction agents. Propofol can cause marked vasodilation and hypotension in autonomic neuropathy, so reduce dose and administer incrementally.
  • Ensure adequate volume status before induction, but avoid indiscriminate fluid loading in patients with renal impairment or cardiac dysfunction.
  • If gastroparesis or reflux is present, use aspiration prophylaxis and a modified rapid-sequence or rapid-sequence induction as clinically indicated.
  • Avoid sudden reductions in sympathetic tone and avoid deep anaesthesia without haemodynamic support.
  • Use short-acting, titratable opioids and a multimodal analgesic plan.
Neuraxial anaesthesia
  • A thoracic epidural can provide excellent analgesia and reduce opioid requirements, but sympathetic blockade can produce profound, poorly compensated hypotension in autonomic neuropathy.
  • If used, insert and dose it incrementally, preferably with invasive BP monitoring and vasopressors immediately available.
  • Epidural analgesia combined with general anaesthesia may be reasonable for open hysterectomy, but is not mandatory.

Haemodynamic management

Autonomic neuropathy may blunt compensatory tachycardia and vasoconstriction. Therefore, hypotension may be severe and disproportionate to apparent blood loss.
  • Establish a baseline BP and target near the patient’s usual pressure. Avoid sustained MAP reductions greater than about 20% from baseline.
  • Treat hypotension early:
    1. Assess blood loss, anaesthetic depth, position, and volume status.
    2. Give small, reassessed crystalloid boluses if hypovolaemia is likely.
    3. Use direct-acting vasopressors early, such as phenylephrine or norepinephrine infusion/boluses, because indirect agents may be less predictable.
  • Bradycardia may respond poorly because of vagal dysfunction. Have atropine, epinephrine, and pacing capability available if severe conduction disease is suspected.
  • Maintain normothermia because thermoregulation may be impaired.
  • Use meticulous positioning and padding because peripheral neuropathy increases pressure-injury risk.

3. Postoperative management

  • Transfer to PACU with continued BP, ECG, oxygen saturation, temperature, and serial glucose monitoring.
  • Consider HDU/ICU observation if there was major blood loss, vasopressor requirement, significant cardiac autonomic neuropathy, renal dysfunction, or poor glycaemic control.
  • Restart basal insulin promptly and safely. Resume usual diabetes therapy only once oral intake is reliable and renal function is stable.
  • Monitor for hypoglycaemia, hyperglycaemia, ketosis, electrolyte disturbance, acute kidney injury, ileus, nausea/vomiting, urinary retention, wound infection, and orthostatic hypotension.
  • Use multimodal analgesia to facilitate mobilisation while minimizing opioid-related ileus and respiratory depression.
  • Give standard venous thromboembolism prophylaxis, early mobilisation, and meticulous wound/pressure-area care.

Concise exam-style conclusion

For total abdominal hysterectomy in a diabetic patient with autonomic dysfunction, the priorities are: first-on-list scheduling, assessment for silent cardiac disease and gastroparesis, prevention of aspiration, cautious titrated induction, invasive BP monitoring when dysfunction is significant, early direct-acting vasopressor use, close glucose and ketone surveillance, avoidance of hypothermia and hypovolaemia, and monitored postoperative care. The major anaesthetic danger is profound hypotension with little compensatory tachycardia due to cardiovascular autonomic neuropathy.
This is a shared conversation. Sign in to Orris to start your own chat.